Gapping up
In reaction to strong earnings/guidance: RTEC +6.5%, AJRD +1.3%, CNV +1%
M&A news: CLTX +79.6% (Celsus Therapeutics and Volution Immuno Pharmaceuticals SA reach an agreement for Volution to become a Celsus subsidiary, via an all-stock transaction), DEPO +6.1% (discloses adoption of poison pill following last week's unsolicited acquisition proposal from Horizon Pharma (HZNP)), BKH +1% (acquires SourceGas Holdings; accretive to EPS beginning first calendar year after closing)
Select Bio/pharma related names showing strength: IBIO +4.7%, SHPG +2.9%, GSK +1.2%
Select China related stocks trading higher: CMCM +3.4%, JKS +2.6%, SFUN +1.6%, NQ +1.3%, BABA +1%
Select travel related names showing strength: JBLU +2.2%, CCL +1.9%, LUV +1.8%, DAL +1.4%
Other news: ANAC +47.7% (announces positive top-line results; Crisaborole achieved statistically significant results on all primary and secondary endpoints; expects to submit a NDA in H1 of 2016), MWE +18.8% (to be acquired by MPLX LP (MPLX) for ~$78.64/share), NBG +13.2% (Greece and EU agree on bailout deal), CLSN +13% (files for 1.95 mln share offering of common stock issuable upon the exercise of outstanding warrants), FXCM +7.7% (still checking), WYNN +4.6% (Macau may allow smoking lounges in casinos, according to Macau Business), DANG +3.5% (announces the formation of a special committee of three independent directors, to consider its received 'going private' proposal), LVS +3.2% (Macau may allow smoking lounges in casinos, according to Macau Business), OGXI +3.1% (announces the continuance of its Phase 3 Enspirit trial, following the recommendation of an independent data monitoring committee), MGM +2.9% (Macau may allow smoking lounges in casinos, according to Macau Business)
Analyst comments: GRPN +4.8% (upgraded to Outperform at Macquarie), IMAX +2.9% (upgraded to Overweight from Neutral at Piper Jaffray), AN +2.2% (upgraded to Overweight from Underweight at Morgan Stanley), NVLS +2.1% (initiated with a Outperform at Robert W. Baird ), FIT +1.9% (initiated with a Buy at Deutsche Bank; initiated with a Overweight at Piper Jaffray),PXD +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), EW +1.6% (upgraded to Outperform at RBC Capital Mkts), SNY +1.5% (upgraded to Buy at Deutsche Bank), IR +1.4% (upgraded to Buy from Hold at Stifel), AAPL +1.1% (upgraded to Buy from Hold at Societe Generale)
In reaction to strong earnings/guidance: RTEC +6.5%, AJRD +1.3%, CNV +1%
M&A news: CLTX +79.6% (Celsus Therapeutics and Volution Immuno Pharmaceuticals SA reach an agreement for Volution to become a Celsus subsidiary, via an all-stock transaction), DEPO +6.1% (discloses adoption of poison pill following last week's unsolicited acquisition proposal from Horizon Pharma (HZNP)), BKH +1% (acquires SourceGas Holdings; accretive to EPS beginning first calendar year after closing)
Select Bio/pharma related names showing strength: IBIO +4.7%, SHPG +2.9%, GSK +1.2%
Select China related stocks trading higher: CMCM +3.4%, JKS +2.6%, SFUN +1.6%, NQ +1.3%, BABA +1%
Select travel related names showing strength: JBLU +2.2%, CCL +1.9%, LUV +1.8%, DAL +1.4%
Other news: ANAC +47.7% (announces positive top-line results; Crisaborole achieved statistically significant results on all primary and secondary endpoints; expects to submit a NDA in H1 of 2016), MWE +18.8% (to be acquired by MPLX LP (MPLX) for ~$78.64/share), NBG +13.2% (Greece and EU agree on bailout deal), CLSN +13% (files for 1.95 mln share offering of common stock issuable upon the exercise of outstanding warrants), FXCM +7.7% (still checking), WYNN +4.6% (Macau may allow smoking lounges in casinos, according to Macau Business), DANG +3.5% (announces the formation of a special committee of three independent directors, to consider its received 'going private' proposal), LVS +3.2% (Macau may allow smoking lounges in casinos, according to Macau Business), OGXI +3.1% (announces the continuance of its Phase 3 Enspirit trial, following the recommendation of an independent data monitoring committee), MGM +2.9% (Macau may allow smoking lounges in casinos, according to Macau Business)
Analyst comments: GRPN +4.8% (upgraded to Outperform at Macquarie), IMAX +2.9% (upgraded to Overweight from Neutral at Piper Jaffray), AN +2.2% (upgraded to Overweight from Underweight at Morgan Stanley), NVLS +2.1% (initiated with a Outperform at Robert W. Baird ), FIT +1.9% (initiated with a Buy at Deutsche Bank; initiated with a Overweight at Piper Jaffray),PXD +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), EW +1.6% (upgraded to Outperform at RBC Capital Mkts), SNY +1.5% (upgraded to Buy at Deutsche Bank), IR +1.4% (upgraded to Buy from Hold at Stifel), AAPL +1.1% (upgraded to Buy from Hold at Societe Generale)